// App-Quantinova.ai

AB1332-HPR : ASSESSING THE PATIENT EXPERIENCE OF LUPUS NEPHRITIS: DEVELOPMENT OF A CONCEPTUAL MODEL AND REVIEW OF EXISTING PATIENT-REPORTED OUTCOME (PRO) MEASURES

Researchers

Presenter

  • P. Berry

Principal Investigators

  • K. Burrows

  • R. Hall

  • A. Gater

  • H. Bradley

  • A. Ward

  • C. Tolley

  • P. Delong

  • E. C. Hsia

Medical Centers

  • , Janssen Global Services, LLC, Horsham, PA, United States of America

  • Adelphi Values, Bollington, United Kingdom

  • Janssen Research & Development, Raritan, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Lupus nephritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved